跳至主要内容
临床试验/NCT04872465
NCT04872465招募中不适用

Efficacy of Bilateral Dorsolateral Prefrontal Theta-burst Stimulation in Elderly Refractory Depression: a Randomized Sham-controlled Study

Kaohsiung Veterans General Hospital.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Hamilton Depression Rating Scale, HAM-D

研究概览

简要总结

The study aim to examine the effect of Thea-burst stimulation over bilateral dorsolateral prefrontal cortex (DLPFC) among patients with LLD on mood condition and relevant biomarkers.

详细描述

Thea-burst stimulation (TBS) is a novel form of rTMS, providing greater modulation effect on neural activity. So far, no study was conducted to use TBS as treatment in LLD. Therefore, we aim to examine the effect of TBS over bilateral dorsolateral prefrontal cortex (DLPFC) among patients with LLD on mood condition and relevant biomarkers. The study used a two-arm, parallel, double-blind, randomized, and sham-controlled design. We plan to enroll sixty patients with LLD, thirty for active intervention and thirty for sham-controlled group. An Magstim Rapid2 stimulator with eight-figure coil was used for stimulation. Location of brain area are based on bilateral DLPFC. 3-pulse 50-Hz bursts was given every 200ms (at 5 Hz) and an intensity of 80% active motor threshold was settled. We initially used cTBS (continuous TBS) over right DLPFC with 120-s train of uninterrupted bursts (1800 pulses) in each session per day. After that, we continuous use iTBS (intermittent TBS, iTBS) over left DLPFC with 2-s train of bursts was repeated every 10 s for a total of 570 s (1800 pulses). Each patient received daily stimulation for two weeks with total ten sessions. The primary outcomes were change of depression severity including response and remission rate. Secondary outcome were biomarkers related to depression. Assessments were administered at baseline, immediately after 5 and 10 sessions of stimulation, and 3 months after the completion of stimulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 60 to 85 years
  • Major depression disorder
  • Under a stable dose of all psychotropic medication during the stimulation period.
  • Exclusion Criteria
  • Having any current psychiatric comorbidity or history of substance dependence.
  • Having active suicidal ideation currently.
  • Having severe physical illness, recent and/or current unstable medical disorders.
  • Having history of cancer or chemotherapy.
  • Dementia or MMSE<
  • Having TMS contraindicated (seizure disorder, history of seizures, metal in the head, pacemakers, history of craniotomy)

排除标准

  • 未提供

结局指标

主要结局

Hamilton Depression Rating Scale, HAM-D

时间窗: Change from baseline after 1, 2 weeks and three months

The Ham-D is the most widely used clinician-administered depression assessment scale. The original version contains 17 items pertaining to symptoms of depression experienced over the past week. A score of 0-7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial.

次要结局

  • Beck anxiety inventory, BAI(Change from baseline after 1, 2 weeks and three months)
  • Beck depression inventory, BDI-II(Change from baseline after 1, 2 weeks and three months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Che-Sheng Chu

Department of Psychiatry, MD, attending physician

Kaohsiung Veterans General Hospital.

研究点 (2)

Loading locations...

相似试验